GW Pharma, the cannabis drug development firm backed by ex Elan executive Tom Lynch has seen its share price rise nine-fold in the last 18 months … …read more
GW Pharma, the cannabis drug development firm backed by ex Elan executive Tom Lynch has seen its share price rise nine-fold in the last 18 months … …read more